Featured Clinical Focus

AML BTK Inhibitors: In-Focus CAR T-Cell Therapy Chronic Lymphocytic Leukemia DLBCL Endometrial Cancer Follicular Lymphoma HCC Hematology HER2-Positive Breast Cancer Lung Cancer Lymphomas Mantle Cell Lymphoma MPNs Multiple Myeloma Ovarian Prostate Cancer Renal Cell Carcinoma Thyroid Cancers

AML BTK Inhibitors: In-Focus CAR T-Cell Therapy Chronic Lymphocytic Leukemia DLBCL Endometrial Cancer Follicular Lymphoma HCC Hematology HER2-Positive Breast Cancer Lung Cancer Lymphomas Mantle Cell Lymphoma MPNs Multiple Myeloma Ovarian Prostate Cancer Renal Cell Carcinoma Thyroid Cancers

View More Brain Cancer Breast Cancer Gastrointestinal Cancer Genitourinary Cancers Gynecologic Cancers Head & Neck Cancers Hematology Leukemias Lung Cancer Lymphomas Melanoma Sarcoma Skin Cancers Thyroid Cancers

Brain Cancer Breast Cancer Gastrointestinal Cancer Genitourinary Cancers Gynecologic Cancers Head & Neck Cancers Hematology Leukemias Lung Cancer Lymphomas Melanoma Sarcoma Skin Cancers Thyroid Cancers

Conference Coverage Conference Listing

Conference Coverage Conference Listing

All Videos Case-Based Peer Perspectives Expert Perspective Virtual Tumor Board Interviews Investigator Perspectives Medical World News Podcasts Precision Medicine

All Videos Case-Based Peer Perspectives Expert Perspective Virtual Tumor Board Interviews Investigator Perspectives Medical World News Podcasts Precision Medicine

All Publications Evolving Paradigms Roundtable Meetings Spotlight Targeted Therapies in Oncology

All Publications Evolving Paradigms Roundtable Meetings Spotlight Targeted Therapies in Oncology

Case-Based Roundtable Series Clinical Trials Partners Precision Medicine Perspectives Press Releases Treatment Resources

Case-Based Roundtable Series Clinical Trials Partners Precision Medicine Perspectives Press Releases Treatment Resources

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
Do Not Sell My Information
Privacy
Terms & Conditions

© 2021 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Featured Clinical Focus

AML
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
DLBCL
Endometrial Cancer
Follicular Lymphoma
HCC
Hematology
HER2-Positive Breast Cancer
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Ovarian
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancers

Clinical FocusSee All >

Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
Do Not Sell My Information
Privacy
Terms & Conditions

© 2021 MJH Life Sciences^™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Ongoing Studies in Frontline mRCC Treatment

November 1, 2016

Toni Choueiri, MD

Toni Choueiri, MD, discusses some of the ongoing clinical trials in metastatic renal cell carcinoma (mRCC).